"As we prepare for the establishment of the Group, we are cognisant of the inherent risks of such a broad reaching reform agenda and the need to balance this with the need for reform to speed up patient access to new medicines," said chief executive Liz de Somer. …
Medicines Australia strikes cautious tone on HTA review implementation group
October 2, 2024 Latest NewsBioPharmaNews of the Day
Latest Video
New Stories
-
Medicines Australia strikes cautious tone on HTA review implementation group
October 2, 2024 - - Latest News -
AbbVie heads the list of Australia's best workplaces in pharma and biotech
October 2, 2024 - - Latest News -
Sigma offers court-enforceable undertaking in response to ACCC concerns
October 2, 2024 - - Latest News -
Pfizer renews commitment to all patients during fourth annual patient week
October 2, 2024 - - Latest News -
Australian company Vaxxas receives significant investment from Endpoints Capital
October 1, 2024 - - Australian Biotech -
Cartherics raises over $15 million in private financing round
October 1, 2024 - - Australian Biotech -
Nyrada’s says lead drug candidate demonstrates significant cardioprotection
October 1, 2024 - - Latest News